Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.43 HKD
Change Today +0.005 / 1.18%
Volume 1.6M
455 On Other Exchanges
Hong Kong
As of 3:01 AM 11/25/15 All times are local (Market data is delayed by at least 15 minutes).

tianda pharmaceuticals ltd (455) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/27/15 - $0.61
52 Week Low
07/8/15 - $0.29
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. The company offers cardio-cerebrovascular, pediatric, cold and respiratory system, anti-infective, and detoxification drugs, as well as complementary health care products comprising bone health, heart health, immune booster, nutritional oil, vitamin and mineral, women’s nutrition, well being, and personal care products. It primarily operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

450 Employees
Last Reported Date: 07/29/15

tianda pharmaceuticals ltd (455) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianda pharmaceuticals ltd (455) Key Developments

Tianda Pharmaceuticals Limited Appoints Shen Bo as Non-Executive Director and Member of the Audit Committee

Tianda Pharmaceuticals Limited announced that according to the Subscription Agreement, Tianda would provide certain undertakings to the Subscriber to procure the Directors to convene a board meeting and the Directors who are nominated by Tianda and its subsidiaries to attend such board meeting and vote in favour of the resolution for the appointment of a nominee to be nominated by the Subscriber as a non-executive Director and a member of the audit committee of the company. As part of it, the Board announce that Mr. SHEN has been appointed as a non-executive Director and a member of the audit committee of the Board with effect from 10 August 2015. Mr. SHEN has entered into a letter of appointment with the company for the appointment of Mr. SHEN as non-executive Director for a term of 2 years and his directorship is subject to the conditions as stated at the letter of appointment and retirement by rotation and re-election at the annual general meetings of the company pursuant to the articles of association of the company. Since May 2014, Mr. SHEN concurrently acts as the executive director of China International Pharmaceutical (Holding) Corporation Limited (a wholly-owned subsidiary of Shanghai Pharmaceuticals Holding Co. Ltd. established in Hong Kong). Since June 2012, Mr. SHEN acts as a non-executive Director of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Tianda Pharmaceuticals Limited Announces Management Changes

The board of directors of Tianda Pharmaceuticals Limited announced that with effect from 3 August 2015, Mr. FANG Wen Quan will resign as the managing director of the company but will remain as the chairman of the Board and an executive director of the company. On the same date, Mr. SHI Shaobin, an executive director of the company, will be appointed and take up the role as the managing director of the company. Mr. SHI served as chairman in Guangzhou Pearl River Piano Group Co. Ltd. which his resignation was on 22 March 2014.

Tianda Pharmaceuticals Limited, Annual General Meeting, Aug 28, 2015

Tianda Pharmaceuticals Limited, Annual General Meeting, Aug 28, 2015., at 10:30 China Standard Time. Location: Suites 2405-2410, 24th Floor, CITIC Tower, No. 1 Tim Mei Avenue. Agenda: To consider the audited consolidated financial statements, the report of the directors and the independent auditor's report of the company for the year ended March 31, 2015; to consider the re-election of executive Directors and independent non-executive Director; to authorize the board of directors to fix the directors' remuneration for the year ending March 31, 2016; to re-appoint Deloitte Touche Tohmatsu as auditor and to authorize the board of directors to fix the remuneration of auditor; to grant a general mandate to the Directors to repurchase shares of the company; to grant a general mandate to the Directors to allot and issue new shares of the company; and to extend the general mandate granted to allot and issue new shares by adding the shares repurchased by the company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
455:HK $0.43 HKD +0.005

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies

Industry Analysis


Industry Average

Valuation 455 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.8x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TIANDA PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at